Stay updated on Tucatinib Combo for HER2+ Breast Cancer Clinical Trial

Sign up to get notified when there's something new on the Tucatinib Combo for HER2+ Breast Cancer Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Tucatinib Combo for HER2+ Breast Cancer Clinical Trial page

  1. Check
    4 days ago
    No Change Detected
  2. Check
    11 days ago
    No Change Detected
  3. Check
    18 days ago
    Change Detected
    Summary
    A new site revision entry (v3.6.3) is added to the history, replacing the previous revision (v3.6.2).
    Difference
    0.1%
    Check dated 2026-07-03T22:13:54.000Z thumbnail image
  4. Check
    25 days ago
    Change Detected
    Summary
    The revision history now shows a new build version (Revision: v3.6.2) replacing the previous v3.6.0, indicating an updated release of the page interface.
    Difference
    0.1%
    Check dated 2026-06-26T23:57:55.000Z thumbnail image
  5. Check
    39 days ago
    Change Detected
    Summary
    The recruitment status was updated to indicate no more participants are being sought. The history also adds a new revision tag v3.6.0 and removes the prior v3.5.5 tag.
    Difference
    0.2%
    Check dated 2026-06-12T14:15:46.000Z thumbnail image
  6. Check
    47 days ago
    Change Detected
    Summary
    The footer revision label was updated from Revision: v3.5.4 to Revision: v3.5.5, signaling a newer site build of the ClinicalTrials.gov page.
    Difference
    0.1%
    Check dated 2026-06-05T09:28:03.000Z thumbnail image
  7. Check
    68 days ago
    Change Detected
    Summary
    A new revision entry v3.5.4 was added to the Record History, and the previous v3.5.3 entry was removed.
    Difference
    0.1%
    Check dated 2026-05-14T23:23:32.000Z thumbnail image
  8. Check
    82 days ago
    Change Detected
    Summary
    The page's revision label was updated to v3.5.3, replacing the previous v3.5.2. This reflects a small site update to how the record history is presented, with no impact on the trial information.
    Difference
    0.1%
    Check dated 2026-04-30T15:32:00.000Z thumbnail image

Stay in the know with updates to Tucatinib Combo for HER2+ Breast Cancer Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Tucatinib Combo for HER2+ Breast Cancer Clinical Trial page.